In multiple Starpharma announcements regarding top line results of DEP-Cabazitaxel and DEP-Docetaxel expected to be released by end of September, the key word is ‘expected.’ That’s the 1st clue.
And, if you listen to the latest CEO interview on A u s B i z from only a week or two ago, you will find your 2nd strong and obvious clue.
Therefore I’m not expecting both trial results to be announced this month. I hope to be pleasantly surprised for at least one result before end of September.
GLTAH
Expectations for September, page-38
-
- There are more pages in this discussion • 35 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $41.31M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.0¢ | 9.9¢ | $14.97K | 151.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 372123 | 9.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.0¢ | 5042 | 1 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| SPL (ASX) Chart |